Who we are
Biozeus has the expertise to develop cutting-edge brazilian pharmaceuticals to the world
Our Technology
Biozeus main technology is derived from the Brazilian Biodiversity
and is classified as a new therapeutic class
Biozeus has the expertise to develop cutting-edge brazilian pharmaceuticals to the world
Biozeus main technology is derived from the Brazilian Biodiversity
and is classified as a new therapeutic class
Biozeus is a Clinical Stage Biotech Company focused on the development of new drugs from Discovery and initial tests, performing preclincal development (animal studies) up to Clinical Stage (human studies).
After we reach the desired development stage, we outlicense the project to worldwide pharmaceutical and biotech companies that will market the technology.
While universities excel in discovery, identification and validation research of leading compounds, they need partners to advance development beyond the early stages. Biozeus was founded in 2012 to fullfil the gap between discovery stages and the market.
Biozeus is backed by a Brazilian venture capital. Its infrastructure and financial management was built based on the scientific & business knowledge necessary to identify, in-license and develop promising human drug discoveries.
Due to our effective project management, based on clear GO and GO/NO-GO points, always conducted within the pharmaceutical industry best practices, only those technologies with high scientific merit and business potential advance to the pivotal clinical stages.
We address one of the biggest challenges facing the life sciences sector today:
How to translate commercially promising health research conducted at the university level into new therapies that reach the market and improve and save lives.
Please subscribe to receive important Biozeus news.
Usamos cookies para analisar o tráfego do site e otimizar sua experiência nele. Ao aceitar nosso uso de cookies, seus dados serão agregados com os dados de todos os demais usuários.